Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Landscape and Language of Molecular Diagnostics for TB Drug Resistance

This online course is designed to provide TB control staff, clinicians, and nurses a brief overview of basic principles of molecular technology and test platforms used for molecular testing of Mycobacterium tuberculosis as a basis for understanding how mutations are associated with drug resistance and what reporting language might be used to describe resistance results.

Author:

Association of Public Health Laboratories, Association of Public Health Laboratories, APHL

Audiences:

Lab Personnel

Topic:

MDR TB, Diagnosis- Laboratory Procedures

View Webpage

Related Materials

Report of Expert Consultations on Rapid Molecular Testing to Detect Drug-Resistant Tuberculosis in the United States

This report presents results from an expert panel convened by CDC to examine the current status of rapid drug-resistance (DR) testing in the United States; to research published evidence and current guidelines; and to provide guidance and make recommendations to CDC for developing a system to provide access to rapid drug-susceptibility testing to all TB control programs in the United States. The panel recommended that CDC establish regional laboratories to provide molecular drug-resistance testing services to state and local TB programs. A phased approach to developing and implementing the testing service was advised. The panel also strongly recommended that CDC immediately establish a service to provide molecular DR testing for TB suspects and patients at high risk of having MDR TB and those deemed high priority by the state or local TB program. The report discusses the background on tests for molecular detection of DR, general considerations and principles for a molecular DR testing service, possible scenarios and scope of testing for such a service, research needs, general recommendations, a communication plan for the report recommendations, and a list of panel members and CDC participants. The appendices include a molecular basis of DR and molecular DR tests, roles and responsibilities in a regional laboratory system for providing for molecular DR testing for TB, and a flow chart of steps in a molecular DR testing service.

Report

CDC’s Molecular Detection of Drug Resistance Service: Rapid Test Results for Real-Time Patient Care

The infographic provides information on the importance of CDC's Molecular Detection of Drug Resistance (MDDR) service, how drug resistance develops, and how CDC assists TB programs. The infographic also includes a case study.

Fact Sheet

Molecular Diagnostics for Tuberculosis: What Are NAATs and How Do You Use Them?

This webinar describes the different NAATs (nucleic acid amplification tests) that are available, including the Gen-Probe MTD test, the Xpert MTB/RIF test, and Pyrosequencing (PSQ), as well as rapid molecular tests for drug resistance, including PSQ, line probe assays, and the CDC MDDR Service.

Webinar

Global resources for the prevention,
management, and elimination of TB.